We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Enlivex

News List

Enlivex: After Review of Phase II Data, Israeli Ministry of Health Authorizes Initiation of a Multi-Center, Randomized Phase IIb Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Pat firstwordpharma
August 16, 2021
Enlivex Therapeutics Ltd. today reported that after reviewing previously-reported Phase II trial data, the Israeli Ministry of Health has authorized the initiation of a proposed Company-sponsored, multi-center, placebo-controlled, randomized, blinded
Enlivex Doses First Two Patients in Allocetra Trial in Severe COVID-19 Patients americanpharmaceuticalreview
October 29, 2020
Enlivex Therapeutics reported the first two patients have been dosed in an investigator-initiated Phase II clinical trial evaluating Allocetra in severe and critical COVID-19 patients.
Enlivex Announces First Patient Dosed in Allocetra Trial for COVID-19 with Respiratory Failure americanpharmaceuticalreview
August 13, 2020
Enlivex Therapeutics announced the first patient has been dosed in an investigator-initiated multi-center clinical trial of AllocetraTM in COVID-19 patients with severe illness and respiratory failures.
Enlivex Initiates Phase II Trial of Allocetra in COVID-19 contractpharma
May 08, 2020
Will assess Allocetra in combination with therapy in patients with lung dysfunction.